Know Cancer

forgot password

Expanded Breast Cancer Registry and Tissue Repository

Open (Enrolling)
Breast Cancer

Thank you

Trial Information

Expanded Breast Cancer Registry and Tissue Repository

Institutions and/or physicians are required to report each new diagnosis of breast cancer to
the New Mexico Tumor Registry (NMTR). The NMTR is a valuable database that provides
information on breast cancer, including trends in incidence and survival. However, relevant
information on breast cancer prognosis and treatment is either not routinely collected or
not readily available to the NMTR. We propose to establish an Expanded Breast Cancer
Registry and Tissue Repository at this institution that could serve as an infrastructure for
collection of this information. Furthermore, a tissue bank will be established for
collection of paired tissue (tumor, buccal cells and blood sample) from patients diagnosed
with breast cancer who consent to providing excess/extra tissue and additional blood for the
Tissue Repository. This tissue bank will serve as a repository from which researchers can
access tissue samples to conduct laboratory-based studies of genetic determinants of breast
cancer risks, prognosis and survival in women with breast cancer seen in this institution.

Inclusion Criteria:

- All patients diagnosed with breast cancer during the study period commencing January
2006, regardless of gender, ethnicity/race, stage of disease or treatment, are

- Potential study participants must meet the eligibility criteria found in the
Eligibility Checklist. The Eligibility Checklist must be completed and stored on
site. Eligibility is confirmed during registration by answering, "yes" to the
question, "Have all eligibility criteria been met?" on the Registration Form.

- For the current proposal, we intend to include only breast cancer patients. However,
the investigators hope to eventually include the following groups: 1) Participants at
intermediate to high risk for breast cancer (documented BRCA or other genetic
syndromes for breast cancer, atypical hyperplasia or LCIS, modified Gail score
>1.66), and 2) Healthy volunteers (no history of cancer). When the infrastructure and
funding is set-up to include these participants, an amended protocol will be
submitted for HRRC review.

Exclusion Criteria:

- Not specified.

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort

Principal Investigator

Melanie Royce, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of New Mexico Cancer Center


United States: Institutional Review Board

Study ID:

INST 0552C



Start Date:

February 2006

Completion Date:

October 2015

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms



University of New Mexico Cancer Center Albuquerque, New Mexico  87131-5636